Завершено
Фаза III
Беларусь
PB006 (натализумаб) · Polpharma Biologics S.A.
Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)